NPM1 and acute myeloid leukemia: The reported results lay the foundations for the development of a label-free tool such as HTFC for statistical studies on the NPM1-related AML disease due to the possibility of performing blood sample analyses based on the collection of 3D and quantitative cells’ datasets and their intracellular CSSI analysis and immersive VR visualization.